ArticleAnimals : an open access journal from MDPI2023
Bivalent Vaccine against
Açucena Veleh Rivas, Angelo Gabriel Vidal Dos Santos, Adrieli Barboza de Souza, Gilson Bueno Junior, Gabriela Fernandes de Souza, Estevam Martins de Souza, Louisiane de Carvalho Nunes, Kelvinson Fernandes Viana
Article in Animals : an open access journal from MDPI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 2 institutions in 1 country.
Açucena Veleh RivasVaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.ORCID 0000-0001-5960-101X
Angelo Gabriel Vidal Dos SantosVaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.
Adrieli Barboza de SouzaVaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.
Gilson Bueno JuniorVaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.
Gabriela Fernandes de SouzaAlquimia Pescados, Foz do Iguaçu 85870-180, Brazil.
Estevam Martins de SouzaAlquimia Pescados, Foz do Iguaçu 85870-180, Brazil.
Louisiane de Carvalho NunesDepartment of Veterinary Medicine, Agricultural Sciences and Engineer Center, Federal University of Espírito Santo, Alegre 29500-000, Brazil.
Kelvinson Fernandes VianaVaccine Development Technology Laboratory, Latin American Institute of Life and Nature Sciences, Federal University of Latin American Integration, Foz do Iguaçu 85870-650, Brazil.ORCID 0000-0002-4657-5446
Universidade Federal da Integração Latino-Americana · BRUniversidade Federal do Espírito Santo · BR
Funding
Fundação Araucária 02/2018
6 · The paper itself
Abstract
One of the main factors limiting tilapia's production is the occurrence of infections caused by
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.